All eyes are on the U.S. Supreme Court, as the nation awaits a ruling from the court

on whether to ban Mitha Pristone, the medication that's used in more than half of abortions

in the U.S.

We turn now to the analysis of Brooks and K-PART, that's New York Times columnist David

Brooks and Jonathan K-PART, Associate Editor for the Washington Post.

It's always great to see you.

Hi, Jonathan.

Really?

So Jonathan, that the court is even weighing this question of national access to Mitha Pristone

really reflects the ways in which the post-row anti-abortion movement has escalated its

effort to eradicate abortion rights everywhere.

Yeah, but this is not surprising.

When the leak of the Alito's doms draft of what we now know is the doms final decision,

the alarm bells started going off immediately about what this would mean for abortion rights,

but also what it would mean for other rights.

And there were conversations about if they do this, what then does that mean?

Will they go after medication abortion?

And with the overturning of row, I've seen this is a pattern, the dog catches the car,

it goes to the states, and then the states go hog wild.

And pushing the envelope, we saw that after Shelby V Holder, where states, once they were

given the right to change their voting laws, they did it, and they went the extra mile.

And what we're seeing here is states doing the same thing.

...